drugset / Trial / NCT01268111

Effect of Vitamin D Replacement on Insulin Sensitivity

NCT01268111

Phase 1 Completed 12 enrolled Texas Tech University Health Sciences Center
RandomizedParallel-groupQuadruple-blindBasic science

Summary

Healthy subjects with low Vitamin D levels will be randomly assigned to either Vitamin D replacement or placebo for a period of 8 weeks. Insulin sensitivity will be measured before and after the intervention, and the changes will be compared between the two groups. This will help us understand if Vitamin D replacement improves insulin sensitivity. Serum Retinol Binding Protein 4 levels will also be measured to see if changes in insulin sensitivity are mediated by RBP4.

Timeline

Start
2011-01
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ergocalciferol Small molecule 50000 iu Oral

Indications

No indication recorded.